Skip to content

Nicholas Tyler Gorden

NPI 1568805810ActiveIndividual· Internal Medicine, Hematology & Oncology· Boise, ID

Internal Medicine, Hematology & Oncology in Boise, Idaho, licensed in ID and OR, with an NPI issued in April 2013. Part D covered 56 prescriptions written in 2024, 73% of them generic. Merck Sharp & Dohme LLC reported $18.09 in payments in 2024, mostly education.

Overview

NPI1568805810
StatusActive
Entity typeIndividual
Sole proprietorNo
NPI issuedApr 16, 2013
Last updated in NPPESJun 23, 2020
Certified by providerJun 23, 2020

Specialties and licenses

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Oct 9, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 10, 2026No match—
New York OMIG · Nov 10, 2026No match—
Ohio Medicaid · Nov 10, 2026No match—
Pennsylvania Medicheck · Nov 10, 2026No match—
Washington HCA · Nov 10, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Not in the public enrollment file of Oct 1, 2026

Part D prescriptions in 2024

Prescriptions (claims)56 · 112 30-day fills
Patients34
Total drug cost$42,783
Generic share73% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2024$18.09 · 1 payment from 1 company

Top paying companies in 2024

CompanyAmountPayments
Merck Sharp & Dohme LLC$18.091

What the 2024 payments were for

  • Education$18.09 · 1 payment

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Internal Medicine, Hematology & Oncology providers in Boise

All Internal Medicine, Hematology & Oncology providers in Idaho →